Skip to main content

Table 1 Tumor and patient characteristics (n = 53)

From: EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy

Characteristics Patients, n (%)
Differentiation  
   High 5 (9.4)
   Moderate 42 (79.3)
   Low 6 (11.3)
FIGO Stage  
   IB 16 (30.2)
   IIA 35 (66.0)
   IIB 1 (1.9)
   IIIB 1 (1.9)
Tumor size  
   > 5 cm 9 (17.0)
   3–5 cm 26 (49.0)
   < 3 cm 18 (34.0)
Lymphatic or vascular space invasion  
   Positive 26 (49.1)
   Negative 27 (50.9)
Vaginal invasion  
   Positive 37 (69.8)
   Negative 16 (30.2)
Parametrial invasion  
   Positive 6 (11.3)
   Negative 47 (88.7)
Age (years)  
   Medium 48
   Range 29–72